InVivo Therapeutics appears to be back on track with its Neuro-Spinal Scaffold, after pausing enrollment in its INSPIRE study last year due to three patients who had received the implant died.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,